Malaria News and Research

Latest Malaria News and Research

Needle-free natural vaccine against malaria: Research

A study published in the journal Science Translational Medicine proposes that preventative treatment with affordable and safe antibiotics in people living in areas with intense malaria transmission has the potential to act as a 'needle-free' natural vaccine against malaria and may likely provide an additional valuable tool for controlling and/or eliminating malaria in resource-poor settings.

12 Aug 2010

Advanced Life Sciences second-quarter net loss decreases to $2.1 million

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced its financial results for the second quarter ended June 30, 2010.

11 Aug 2010

Elsevier launches Global Malaria Resource

Elsevier, the world-leading publisher of scientific, technical and medical information products and services, today announced the launch of Malaria Nexus, Elsevier's Global Malaria Resource, http://www.malarianexus.com.

11 Aug 2010

Tamir Biotechnology's three compounds effective show potential for yellow fever

Tamir Biotechnology, Inc.(formerly Alfacell Corporation) announced today that scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID) confirmed that testing of three of our company's compounds showed in vitro results rarely seen before by the U.S. government for yellow fever.

11 Aug 2010

U.S. Senators introduce legislation to encourage R&D aimed at neglected pediatric diseases

"New bipartisan legislation was introduced in the U.S. Senate last week which seeks to encourage innovative [research and development] R&D by drugmakers aimed at treating rare and neglected pediatric diseases," PharmaTimes reports.

11 Aug 2010

Opinions: HIV prevention research; Foreign aid; Sanitation; Aid, self-reliance

"Microbicides, vaccines and other new approaches will one day join proven HIV-prevention strategies, including condoms, male circumcision and clean needles. How soon that day comes will depend on whether funders and the scientific community can develop the more collaborative approaches to HIV prevention research needed to address this fast-moving epidemic," Global HIV Vaccine Enterprise leaders Alan Bernstein, executive director, and Peter Piot, chair, write in a Globe and Mail opinion piece.

11 Aug 2010

Surveillance systems find no major disease outbreaks since Haiti quake; Media examine aid disbursements

Haitian and U.S. public health experts recently reported that two new surveillance systems set up in Haiti after the January earthquake showed that no major disease outbreaks had developed and that the new systems could be part of the foundation of the country's health system in the long term, Reuters reports. The findings were published Friday in the CDC's Morbidity and Mortality Weekly Report.

10 Aug 2010

GWA Study helps scientists identify genetic variant that increases tuberculosis susceptibility in African populations

Scientists have identified a genetic variant which increases susceptibility to tuberculosis (TB) in African populations using a technique known as a genome-wide association (GWA) study. This is the first novel disease variant to be identified using this technique in Africans and demonstrates that such studies are viable in African populations, which have a high degree of genetic diversity.

9 Aug 2010

Bloomberg Businessweek explores growing trend in pharma to license, donate HIV drugs

"Pharmaceutical companies, once blasted as uncaring or downright greedy for charging thousands of dollars for a year's worth of AIDS medicines … in poor countries, lately have been slashing prices and licensing their drugs for free or nominal cost to nonprofits or local manufacturers in the developing world," Bloomberg BusinessWeek writes in an analysis piece that examines how this trend, combined with a growing capability among aid agencies to distribute drugs, has the potential to increase access to HIV/AIDS drugs worldwide.

7 Aug 2010

GenVec signs new agreement with Novartis for supply of services relating to development materials

GenVec, Inc. today announced a new agreement for the supply of services relating to development materials with Novartis, related to the companies' collaboration in hearing loss and balance disorders. Under this new agreement, GenVec could receive approximately $13 million over four years to manufacture clinical trial material for up to two lead candidates.

7 Aug 2010

Equatorial Guinea, ECCAS partner to form network to fight H1N1, HIV

Equatorial Guinea (Republica de Guinea Ecuatorial) and the Global Viral Forecasting Initiative, along with several Central African States, have partnered with the Economic Community of Central African States to form a network to fight H1N1 and HIV. The purpose of the network's recent forum was to share knowledge and best practices, and to collect data and prevention procedures among military health professionals in the region.

7 Aug 2010

Recent releases in Global Health

According to a Lancet Comment, "alcohol remains conspicuously absent from the larger field of research and programming in HIV and substance use. ... Patterns of hazardous alcohol consumption prevail in countries with the most severe HIV epidemics, notably eastern and southern Africa." In addition, "hazardous drinking patterns also dominate in the concentrated epidemics of eastern Europe and Asia, where alcohol use by injecting drug users and other marginalised groups might be an additional barrier to effective efforts to prevent HIV infection."

7 Aug 2010

GenVec reports net loss of $4.2M for second-quarter 2010

GenVec, Inc. today announced its financial results for the second quarter ended June 30, 2010.

6 Aug 2010

Research on human disease origins to predict, prevent next outbreak

Most infectious diseases infect multiple host species, but to date, efforts to quantify the frequency and outcome of cross-species transmission (CST) of these diseases have been severely limited.This lack of information represents a major gap in knowledge of how diseases emerge, and from which species they will emerge.A paper published this week in the journal Science by a team of researchers led by Daniel Streicker of the University of Georgia has begun to close that gap.

6 Aug 2010

Researchers map malaria parasite P vivax; Nearly 3B people at risk of infection in 2009

A new evidence-based map estimates that in 2009 2.85 billion people lived "at risk of infection" with the malaria parasite Plasmodium vivax, BMJ News reports. As described in a study, published Tuesday in PLoS Neglected Tropical Diseases, P vivax "is more widespread and potentially represents a greater burden on human health in some parts of the world than P falciparum, the species usually associated with the greatest mortality and morbidity," BMJ News writes (Moszynski, 8/3).

5 Aug 2010

Nature News examines how scientists, farmers are working to meet the growing demand for artemisinin

"From bust to boom to bust again: artemisinin, the key ingredient of front-line antimalarial drugs, is entering the third chapter of its turbulent history," Nature News writes in an article that examines the challenges scientists and farmers are facing as they attempt to keep up with the growing demand for the compound just as a "$343-million initiative starts to battle malaria through hugely subsidized medicines."

5 Aug 2010

President Obama, Sec. of State discuss U.S. commitment to development, fighting disease in Africa with young African leaders

During a gathering of over 100 young African business and civil leaders at the White House on Tuesday, President Barack Obama "urged [them] to help spur economic development and fight corruption, disease and extremism on the continent," MSNBC's "First Read" blog reports.

5 Aug 2010

Asian ministers review MDGs progress

South Asia is "lagging behind" in poverty and hunger reduction and is "in danger" of missing key Millennium Development Goal (MDG) targets, a U.N. official told Asian ministers gathered to discuss MDGs progress, Agence France-Presse reports. At the meeting, "senior officials told delegates from dozens of countries that global food, energy and financial crises in recent years had jeopardized progress toward achieving the goals set for 2015," the news service writes.

4 Aug 2010

Telormedix, Swiss TPH Institute collaborate to develop effective vaccines for Malaria, Buruli Ulcer

Telormedix, a clinical stage biopharmaceutical company using targeted immunity to treat cancer and other diseases, today announced the start of a collaboration with the Swiss Tropical and Public Health Institute (Swiss TPH) on a pilot study using Telormedix's adjuvant, TMX-201, in connection with immunization for Malaria and Buruli Ulcer.

3 Aug 2010

Researchers develop techniques to identify evolution of drug resistance strains of malaria

Researchers at Case Western Reserve University developed techniques to quickly identify evolution of drug resistance in strains of malaria. Their goal is to enable the medical community to react quickly to inevitable resistance and thereby save lives while increasing the lifespan of drugs used against the disease.Currently, disease monitoring requires months of clinical trials. The new methods can provide more information in just days, and far cheaper.

3 Aug 2010

Malaria News and Research

Latest Malaria News and Research

Needle-free natural vaccine against malaria: Research

Advanced Life Sciences second-quarter net loss decreases to $2.1 million

Elsevier launches Global Malaria Resource

Tamir Biotechnology's three compounds effective show potential for yellow fever

U.S. Senators introduce legislation to encourage R&D aimed at neglected pediatric diseases

Opinions: HIV prevention research; Foreign aid; Sanitation; Aid, self-reliance

Surveillance systems find no major disease outbreaks since Haiti quake; Media examine aid disbursements

GWA Study helps scientists identify genetic variant that increases tuberculosis susceptibility in African populations

Bloomberg Businessweek explores growing trend in pharma to license, donate HIV drugs

GenVec signs new agreement with Novartis for supply of services relating to development materials

Equatorial Guinea, ECCAS partner to form network to fight H1N1, HIV

Recent releases in Global Health

GenVec reports net loss of $4.2M for second-quarter 2010

Research on human disease origins to predict, prevent next outbreak

Researchers map malaria parasite P vivax; Nearly 3B people at risk of infection in 2009

Nature News examines how scientists, farmers are working to meet the growing demand for artemisinin

President Obama, Sec. of State discuss U.S. commitment to development, fighting disease in Africa with young African leaders

Asian ministers review MDGs progress

Telormedix, Swiss TPH Institute collaborate to develop effective vaccines for Malaria, Buruli Ulcer

Researchers develop techniques to identify evolution of drug resistance strains of malaria

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Malaria News and Research

Latest Malaria News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in